RPGR gene therapy presents challenges in cloning the coding sequence
<p><strong>Introduction:</strong> Currently, there are three Phase I/II clinical trials based on gene therapy ongoing to test different AAV.RPGR or deleted RPGR vectors on patients affected by X-linked retinitis pigmentosa. These three vectors differ in the adeno-associated viral (...
Main Authors: | Martinez-Fernandez De La Camara, C, Cehajic-Kapetanovic, J, MacLaren, RE |
---|---|
格式: | Journal article |
语言: | English |
出版: |
Taylor and Francis
2019
|
相似书籍
-
Clinical applications of microperimetry in RPGR-related retinitis pigmentosa: a review
由: Buckley, TMW, et al.
出版: (2021) -
Characterizing visual fields in RPGR related retinitis pigmentosa using octopus static-automated perimetry
由: Buckley, TMW, et al.
出版: (2022) -
Association of a novel intronic variant in RPGR with hypomorphic phenotype of x-linked retinitis pigmentosa
由: Cehajic-Kapetanovic, J, et al.
出版: (2020) -
Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
由: Taylor, LJ, et al.
出版: (2023) -
Low luminance visual acuity and low luminance deficit in choroideremia and RPGR-associated retinitis pigmentosa
由: Wood, LJ, et al.
出版: (2021)